<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="65633">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02149238</url>
  </required_header>
  <id_info>
    <org_study_id>New Drink</org_study_id>
    <nct_id>NCT02149238</nct_id>
  </id_info>
  <brief_title>Interaction of Cocoa Methylxanthines With Cocoa Flavanol Related Vascular Effects</brief_title>
  <acronym>New Drink</acronym>
  <official_title>Acute Study to Investigate the Interaction of Cocoa Methylxanthines With Cocoa Flavanol Related Vascular Effects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Heinrich-Heine University, Duesseldorf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Heinrich-Heine University, Duesseldorf</source>
  <oversight_info>
    <authority>Germany: Ethics Commission</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Epidemiological studies suggest that certain foods rich in flavanols, including cocoa
      products, red wine, and tea, are associated with decreased cardiovascular mortality and
      morbidity. Dietary interventional studies have corroborated this finding and showed that
      flavanols can acutely and after sustained ingestion improve surrogate markers of
      cardiovascular risk including endothelial function. Endothelial dysfunction is the key event
      in the development and progression of cardiovascular disease. Aging is the major
      non-modifiable cardiovascular risk factor associated with progressive decline in endothelial
      function, vascular stiffening and increase in blood pressure.

      However, in addition to flavanols, other potentially bioactive compounds are present in
      cocoa, in particular methylxanthines. Little is known about the vascular effects of cocoa
      methylxanthines, i.e. mainly theobromine, in particular when consumed together with
      flavanols in cocoa products. The aim of the study is to characterize the nutrient-nutrient
      interaction between cocoa flavanols and cocoa methylxanthines.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2011</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Basic Science</study_design>
  <primary_outcome>
    <measure>Endothelial function</measure>
    <time_frame>2 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>Flow mediated dilatation (FMD)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Plasma flavanol metabolites</measure>
    <time_frame>2 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>Measured by HPLC</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pulse wave velocity</measure>
    <time_frame>2 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>Measured by SphygmoCor</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ambulatory blood pressure</measure>
    <time_frame>2 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>automatical measurements</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Circulation angiogenetic cells</measure>
    <time_frame>2 hours</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">36</enrollment>
  <condition>Cardiovascular Diseases</condition>
  <arm_group>
    <arm_group_label>flavanol rich drink intervention</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>flavanol rich drink</description>
  </arm_group>
  <arm_group>
    <arm_group_label>methylxanthine rich drink intervention</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>methylxanthine rich drink</description>
  </arm_group>
  <arm_group>
    <arm_group_label>flavanol + methylxanthine rich drink intervention</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>flavanol + methylxanthine rich drink</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>flavanol</intervention_name>
    <arm_group_label>flavanol rich drink intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>methylxanthine</intervention_name>
    <arm_group_label>methylxanthine rich drink intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>flavanol + methylxanthine</intervention_name>
    <arm_group_label>flavanol + methylxanthine rich drink intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy male subjects

          -  &gt;18 years

        Exclusion Criteria:

          -  acute inflammation

          -  cardiac arrhythmia

          -  renal failure

          -  heart failure (NYHA II-IV)

          -  diabetes mellitus

          -  CRP &gt; 1 mg/dl

          -  malignant disease
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christian Heiss, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Division of Cardiology, Pulmonology and Vascular Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Malte Kelm, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Division of Cardiology, Pulmonology and Vascular Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christian Heiss, MD</last_name>
    <phone>00492118118800</phone>
    <email>Christian.Heiss@med.uni-duesseldorf.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Rabea Wagstaff, B.Sc., M.A.</last_name>
    <phone>00492118118800</phone>
    <email>rabea.wagstaff@med.uni-duesseldorf.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Division of Cardiology, Pulmonology and Vascular Medicine</name>
      <address>
        <city>Duesseldorf</city>
        <zip>40225</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Heiss, MD</last_name>
      <phone>00492118118800</phone>
      <email>christian.heiss@med.uni-duesseldorf.de</email>
    </contact>
    <contact_backup>
      <last_name>Rabea Wagstaff, B.Sc., M.A.</last_name>
      <phone>00492118118800</phone>
      <email>rabea.wagstaff@med.uni-duesseldorf.de</email>
    </contact_backup>
    <investigator>
      <last_name>Christian Heiss, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Roberto Sansone, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 26, 2014</lastchanged_date>
  <firstreceived_date>May 22, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Heinrich-Heine University, Duesseldorf</investigator_affiliation>
    <investigator_full_name>Klinik für Kardiologie, Pneumologie und Angiologie</investigator_full_name>
    <investigator_title>Klinik für Kardiologie, Pneumologie und Angiologie</investigator_title>
  </responsible_party>
  <keyword>flavanols</keyword>
  <keyword>cardiovascular effects</keyword>
  <keyword>nutrition-nutrition interaction</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
